DexCom (DXCM) Tops Q3 EPS by 30c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $134.30 --0%
Revenue Growth %: +22.7%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +22.7%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.94, $0.30 better than the analyst estimate of $0.64. Revenue for the quarter came in at $500.9 million versus the consensus estimate of $476.75 million.
GUIDANCE:
DexCom sees FY2020 revenue of ~$1.9 billion, versus the consensus of $1.87 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- PPG Industries (PPG) Reports In-Line Q1 EPS, offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
